NEWS | Chic >
CHIC scientists and artists meeting at Keygene
Scientists and artists meet at KeyGene -an independent biotechnology company- in Wageningen, last week.
The CHIC project aimed at implementing New Plant Breeding Techniques in chicory, in order to establish it as a multipurpose crop for sustainable molecular farming of products with consumer benefits. Chicory contains many healthy substances which can, for example, slow down the growth of fungi and bacteria. The crop is very difficult to breed using the current technologies, breeding, and selection, and it is also hard to increase production of the healthy components. New breeding techniques such as CRISPR-Cas can be used to develop new chicory varieties, which contain more fibers and components suitable for medicinal applications.
New approach
CHIC aims to implement innovative communication tools, including cultural communication and linking art to science, to improve understanding of New Plant Breeding Techniques by the public and for informed decision making.
Learn more: http://chicproject.eu/what-is-chic/
More news about this project:
Technical and risk and regulatory assessment of NPBTs update
CHIC is the Chicory Innovation Consortium. The project’s main objectives are 1) to implement New Plant Breeding Techniques (NPBTs) in chicory in order to establish it as a multipurpose crop for the production of health-related products with clear benefits for consumers, and 2) to develop co-innovation pathways with stakeholders for game-changing technologies, such as NPBTs.
Augmented reality educational game for the young generation!
Gene editing, or genome editing in augmented reality, is a process in which small intended changes in the DNA are introduced in the genome of a living organism such as plants.
Implementation of NPBTs in chicory for bioactive terpenes update
CHIC is the Chicory Innovation Consortium. The project’s main objectives are 1) to implement New Plant Breeding Techniques (NPBTs) in chicory in order to establish it as a multipurpose crop for the production of health-related products with clear benefits for consumers, and 2) to develop co-innovation pathways with stakeholders for game-changing technologies, such as NPBTs.